Patent · US Active

Methods for diagnosing irritable bowel syndrome

US8709733B2 · kind B2 · utility

1Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 17, 2012
Grant dateApr 29, 2014
Priority date
Expiry dateJan 17, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/147777
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides an ELISA assay for the determination of serum mast cell β-tryptase levels using rabbit anti-tryptase as the capture antibody and alkaline phosphatase conjugated G3 as the detecting antibody. Luminescent substrate CPSD was used to enhance the assay sensitivity. Also provided are methods for aiding in the diagnosis of irritable bowel syndrome by detecting the serum level of β-tryptase, histamine and/or prostaglandin E2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.